Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 326 participants.

Also called NCT07511257

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 326 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07511257
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07511257. Randomized; no masking; primary purpose treatment. Start 2026-02-11 (actual); primary completion 2029-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Acronym
OVER-TIME II
Condition
Coronary Artery Ectasia
Condition
Acute Coronary Syndromes (ACS)
Condition
STEMI - ST Elevation Myocardial Infarction
Condition
NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Intervention (Drug)
Aspirin 100 mg
Intervention (Drug)
Clopidogrel 75 mg
Intervention (Drug)
Rivaroxaban 15 mg
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez (class: other)

Record details

Record id
cardio:ct-nct07511257
Content hash
8476f63ca89d63dbf8b4d056828d81aa6c54620c10d4d6bca34e8e9abfc46291